v3 Template
N

NEOK Bio, Inc.

Biotechnology / Healthcare ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$75.0M
Funding Rounds
1
Last Funding
2025-11-04

About NEOK Bio, Inc.

NEOK Bio is dedicated to transforming cancer treatment through scientific innovation, focusing on solving therapeutic challenges and improving patient outcomes with cutting-edge antibody drug conjugates (ADCs).

Products & Services

Bispecific Antibody Drug Conjugates (ADCs):A pipeline of differentiated bispecific ADCs aimed at treating cancer with a dual-targeting approach for improved safety and efficacy, particularly for solid tumor cancers with unmet needs.

Specialties

Antibody Drug Conjugates (ADCs) Bispecific ADCs Oncology Drug Development Dual-Targeting Strategy Precision Medicine for Cancer

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 75000000
MR: -
FA: $75 million
FAN: 75000000 		D: 2025-11-04
FD: 2025-11-04 		1 investors
Series A Latest
2025-11-04
$75.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Sang Hoon Lee

Board Member

J

Jerry Lee

Board Member

M

Mayank Gandhi

CEO, Board Member

M

Mayank Gandhi, M.D.

CEO

M

Morris Rosenberg

CMC

P

Patrick Zweidler-McKay, M.D., Ph.D

Clinical Development

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

NEOK Bio, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~150 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro